<code id='BD13735444'></code><style id='BD13735444'></style>
    • <acronym id='BD13735444'></acronym>
      <center id='BD13735444'><center id='BD13735444'><tfoot id='BD13735444'></tfoot></center><abbr id='BD13735444'><dir id='BD13735444'><tfoot id='BD13735444'></tfoot><noframes id='BD13735444'>

    • <optgroup id='BD13735444'><strike id='BD13735444'><sup id='BD13735444'></sup></strike><code id='BD13735444'></code></optgroup>
        1. <b id='BD13735444'><label id='BD13735444'><select id='BD13735444'><dt id='BD13735444'><span id='BD13735444'></span></dt></select></label></b><u id='BD13735444'></u>
          <i id='BD13735444'><strike id='BD13735444'><tt id='BD13735444'><pre id='BD13735444'></pre></tt></strike></i>

          Home / comprehensive / explore

          explore


          explore

          author:knowledge    Page View:41492
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In